Evidence map›Paper›PMID 33023896›Full record

ArticleBMJ open diabetes research & care2020

Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort.

Marit de Jong, Marieke J Oskam, Simone J S Sep, Behiye Ozcan, Femke Rutters, Eric J G Sijbrands, Petra J M Elders, Sarah E Siegelaar, J Hans DeVries, Cees J Tack and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  10. Achievement of treatment targets among patients with type 2 diabetes in 2015 and 2020 in Canadian primary care.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Sex and ethnic differences in the cardiovascular complications of type 2 diabetes.Therapeutic advances in endocrinology and metabolism · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

Marit de Jong *Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0001-9260-4458
Marieke J Oskam *Department of Internal Medicine, School for Cardiovascular Diseases CARIM, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Simone J S SepDepartment of Internal Medicine, School for Cardiovascular Diseases CARIM, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Behiye OzcanDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Femke RuttersDepartment of Epidemiology and Biostatistics, Amsterdam UMC - VUMC location, Amsterdam, The Netherlands.
Eric J G SijbrandsDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Petra J M EldersDepartment of General Practice and Elderly Care, Amsterdam Public Health Research Institute, Amsterdam UMC - VUMC location, Amsterdam, The Netherlands.
Sarah E SiegelaarDepartment of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
J Hans DeVriesDepartment of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Cees J TackDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Marielle SchroijenDepartment of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-8865-0224
Harold W de ValkDepartment of Internal Medicine, Universty Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Evertine J AbbinkDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Coen D A StehouwerDepartment of Internal Medicine, School for Cardiovascular Diseases CARIM, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Ingrid JazetDepartment of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Bruce H R WolffenbuttelDepartment of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands bwo@umcg.nl.
Sanne A E PetersJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0003-0346-5412
Miranda T SchramDepartment of Internal Medicine, School for Cardiovascular Diseases CARIM, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0001-8113-7604
Diabetes Pearl from the Parelsnoer Initiative
Maastricht University Medical Centre · NLAmsterdam University Medical Centers · NLErasmus MC · NLLeiden University Medical Center · NLRadboud University Nijmegen · NLUtrecht University · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLThe George Institute for Global Health · GBUniversity Medical Center Groningen · NL

Funding

Medical Research Council MR/P014550/1
6 · The paper itself

Abstract

introductionSex differences in cardiometabolic risk factors and their management in type 2 diabetes (T2D) have not been fully identified. Therefore, we aimed to examine differences in cardiometabolic risk factor levels, pharmacological treatment and achievement of risk factor control between women and men with T2D. RESEARCH DESIGN AND

methodsCross-sectional data from the Dutch Diabetes Pearl cohort were used (n=6637, 40% women). Linear and Poisson regression analyses were used to examine sex differences in cardiometabolic risk factor levels, treatment, and control.

resultsCompared with men, women had a significantly higher body mass index (BMI) (mean difference 1.79 kg/m

conclusionsIn this Dutch T2D population, women had a slightly different cardiometabolic risk profile compared with men and a substantially higher BMI. Women had a higher probability of being treated with antihypertensive medication in the presence of high CVD risk and elevated SBP than men, and were less likely than men to achieve treatment targets for HbA

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Cardiometabolic Risk FactorsCross-Sectional StudiesFemaleHumansMaleRisk FactorsSex Characteristicsdiabetes mellitusepidemiologyhealthcare disparitiestype 2

Identifiers

PMID33023896
PMCPMC7539590
OpenAlexW3092245407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.